AI GxP validation for regulated life sciences
Integration

Validating an ELN-LIMS Integration Under GAMP 5: A Step-by-Step Technical Guide

The complete GAMP 5 validation lifecycle for an ELN-LIMS integration: from URS and risk classification through IQ/OQ/PQ execution, change control, and ongoing oversight.

Cybroscape Technologies6 min read

Key takeaway

The complete GAMP 5 validation lifecycle for an ELN-LIMS integration: from URS and risk classification through IQ/OQ/PQ execution, change control, and ongoing oversight.

Validating an ELN-LIMS integration under GAMP 5 is not the same as validating the ELN or the LIMS. The integration is a separate software system — a Category 4 or 5 system depending on how much of it is custom — and it requires its own validation package: its own URS, its own risk assessment, its own IQ/OQ/PQ protocols, and its own change control process. Teams that validate the ELN and LIMS but leave the integration between them unvalidated have a compliance gap at the highest-risk point in their data flow.

Step 1: Define the URS for the integration

The User Requirement Specification for an ELN-LIMS integration defines what the integration must do, not how it does it. The URS should cover: which ELN record types transfer to which LIMS entities (and in what direction — ELN-to-LIMS only, or bidirectional?); the trigger for each transfer (event-driven on ELN approval, scheduled batch, manual initiation?); the data fields transferred for each record type; the quality checks applied at the integration layer before acceptance by the LIMS; the handling of failed transfers (retry logic, alerting, manual fallback); and the performance requirements (maximum transfer latency, minimum throughput). Each URS requirement gets a unique identifier that will link through the risk assessment and into the test cases. Cybroscape GxP Copilot supports URS authoring with structured requirement capture.

Step 2: GAMP 5 classification of the integration

The GAMP 5 classification determines the depth of the validation programme. Category 4 (configurable, no custom code): a vendor-supplied connector between two validated systems, configured through a UI or configuration file, with no bespoke transformation logic. Validation depth: IQ (installation and configuration verification), OQ (functional testing of each data flow type), no unit tests or code review required. Category 5 (custom): any integration with bespoke code — Python scripts, custom APIs, home-built transformation logic. Validation depth: full software development lifecycle evidence — unit tests for every custom function, code review records, source control history, IQ, OQ, PQ. The classification decision belongs to the validation team and should be documented in the validation plan before a line of code is written.

Step 3: Risk assessment for the integration

The interface risk assessment identifies the failure modes for each data flow type and scores each against severity, probability, and detectability. Critical failure modes for an ELN-LIMS integration include: silent transfer failure (high severity — QC data missing from LIMS without alert); incorrect field mapping (high severity — wrong value in release-critical LIMS field); duplicate transfer (medium severity — duplicate records in LIMS cause reconciliation failure); schema mismatch (high severity if undetected — values arrive in wrong format and are silently accepted). For each failure mode, the risk assessment documents the existing controls (schema validation, delivery receipts, monitoring) and the residual risk. The risk assessment drives the OQ test case coverage — high-risk failure modes get multiple test cases covering boundary conditions and error paths.

Step 4: IQ — Installation Qualification

The IQ for an ELN-LIMS integration verifies that the integration infrastructure is installed and configured correctly before any functional testing begins. IQ checklist: integration server software version matches the validated version; connector version matches the validated version; configuration parameters (API endpoints, credentials, field mappings, transfer schedules) match the approved configuration document; message queue infrastructure (if present) is installed and accessible; monitoring and alerting are configured and tested; network connectivity between ELN, integration layer, and LIMS is verified with documented test results. The IQ is executed in the target environment (staging or production qualification environment, not development). All IQ results are signed by the executing engineer and reviewed by QA.

Step 5: OQ — Operational Qualification

The OQ for an ELN-LIMS integration tests the functional requirements against the URS. OQ must include: happy path tests for every data flow type (ELN result record transfer, method transfer, sample metadata transfer); field mapping verification for every field in every record type (not just a spot check — every mapped field must be verified to arrive in the correct LIMS field with the correct value and data type); error condition tests for every identified failure mode (LIMS unavailable — does the message queue hold and retry? Schema mismatch — is the record rejected with an alert rather than silently accepted? Duplicate delivery — is the idempotency check working?); and performance tests (can the integration handle the peak expected transfer volume without exceeding the latency requirement?). Each OQ test is a formal protocol step with expected results, actual results, and pass/fail disposition.

Step 6: PQ — Performance Qualification

The PQ tests the integration in the actual operational environment with real or representative operational data. For an ELN-LIMS integration, PQ typically runs over a defined period (two to four weeks) in production or a production-equivalent environment, monitoring: total records transferred vs total records expected; error rate (target: zero missed transfers, with documented handling for any that occur); transfer latency (every transfer completes within the URS-defined SLA); data integrity checks (a sample of transferred records is manually verified against the source ELN records). PQ exit criteria should be stated in the validation plan and agreed with QA before PQ begins — not defined after the results are in hand.

Step 7: Ongoing change control and periodic review

Post-validation, the integration must be maintained under the same change control discipline as the systems it connects. Changes requiring formal change control: API version upgrade in either the ELN or LIMS; addition of a new data flow type; change to a field mapping; change to a quality check threshold or logic; upgrade of the integration software or connector version. Periodic review (at least annual): confirm the validation remains current given any changes to the integration, the connected systems, or the regulatory environment; review the integration monitoring logs for anomalies; confirm the transfer record completeness for the review period. Cybroscape GxP Copilot handles change control and periodic review for the ELN and LIMS systems; the integration layer is handled by our data integrity (ALCOA+) team.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

Part of our guide to GxP software — categories, evaluation criteria and how the platforms compare.

ELN
LIMS
MES
ERP
CompleteAttributableUnchanged
Each system can be validated and the data can still break between them. Every handoff needs its own check that the data arrived complete, attributable and unchanged.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.

Sources

Primary documents referred to on this page, from their official publishers.

validate eln lims integration gamp 5gamp 5 eln lims validationeln lims interface validation step by stepvalidated eln lims integration

Keep reading

All articles
IntegrationMid-Sized Pharma ELN-LIMS Integration: Case Studies and Lessons From the FieldReal integration patterns from mid-sized pharma teams: what worked, what failed, what the validation decisions were, and what the inspection outcomes looked like. · 6 min readIntegrationELN-LIMS Integration for Mid-Sized Pharma: Architecture, Validation, and Common PitfallsHow mid-sized pharma teams architect, validate, and maintain ELN-to-LIMS integrations: the GAMP 5 framework applied, and real failure modes from the field. · 5 min readGxP Software12 Best GxP Software Platforms Compared (2026): Validation, eQMS, LIMS & MESThe 12 best GxP software platforms in 2026 compared side by side: AI & paperless validation (Cybroscape GxP Copilot, Kneat, ValGenesis, Veeva, Sware Res_Q, Valkit.ai), eQMS (Cybroscape eQMS, Veeva, MasterControl, Qualio, SimplerQMS), LIMS and MES. · 7 min readGxP SoftwareGxP Software for Biotech Startups: What to Buy First, What Can Wait, and What to SkipThe GxP software buying guide for seed-to-Series-B biotech companies: which systems to prioritise, how to validate them without a dedicated QA team, and how to avoid the enterprise-software trap. · 5 min readGxP SoftwareGxP Software Validation Checklist: Every Step From URS to Go-Live Under GAMP 5 and CSAA step-by-step checklist for validating any GxP software system (URS, risk assessment, vendor qualification, IQ/OQ/PQ, traceability matrix, and Validation Summary Report) with CSA and GAMP 5 alignment. · 5 min readTrainingGxP Training Requirements: What Regulators Expect, How to Document It, and Where Most Teams FailThe complete guide to GxP training: regulatory basis (FDA, EMA, ICH Q10), training matrix design, SOP curriculum, competency assessment, and the documentation structure that satisfies inspectors. · 5 min readRegionalGxP Validation in Ireland: What Makes the Irish Pharma Manufacturing Hub DifferentIreland hosts 9 of the top 10 global pharma companies. Here is what makes validation in Irish pharma operations different: the HPRA inspection culture, multi-site complexity, and the talent gap that shapes every project. · 5 min readRegionalGxP Validation in Switzerland: What the Basel Pharma Cluster Expects From Its Validation PartnersSwitzerland is where Novartis, Roche, and Lonza set the global standard. Here is what GxP validation looks like when your neighbours literally wrote the quality playbook. · 5 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.